Answers are grounded in this paper and cite their sources.
Pituitary tumours account for~16% of central nervous system tumors and they are the second most frequently reported histology in this group. Due to their small size, pituitary surgery is challenging and precise lesion localization through imaging is therefore a critical factor for a successful outcome. Simultaneous positron emission tomography and magnetic resonance imaging is well suited for lesion identification and localization but it requires accurate attenuation correction (AC) to ensure optimal positron emission imaging (PET) imaging. Atlas-based AC methods are often used for this purpose, as they overcome the difficulty of estimating bone tissue density with conventional MR sequences. However, atlas methods can only partially account for interpatient variability. The goal of this paper was to investigate whether direct bone measurement, by means of a zero echo time MR sequence, can significantly improve the accuracy of pituitary tumor imaging with PET.
No takes yet. Share an insight, caveat, or question.
Delso et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: